
    
      Objective 1: To test the effectiveness of the GO! To Sleep program at improving the sleep
      duration and sleep quality in women at high risk of breast cancer.

      Objective 2: To test the effectiveness of improvements in sleep quality and/or duration due
      to the GO! To Sleep program on biomarkers of inflammation in women at high risk of breast
      cancer.

      Objective 3: To evaluate the effectiveness of improvements in health-related quality of life
      after the GO! To Sleep in women at high risk of breast cancer.
    
  